Published in J Acquir Immune Defic Syndr on July 01, 2010
Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection. PLoS One (2013) 1.35
Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient. Antivir Ther (2011) 1.32
HIV-1 Genetic Variability and Clinical Implications. ISRN Microbiol (2013) 1.10
Large-scale analysis of the prevalence and geographic distribution of HIV-1 non-B variants in the United States. J Clin Microbiol (2013) 0.95
Controlling the HIV/AIDS epidemic: current status and global challenges. Front Immunol (2012) 0.92
Phylogenetic and geospatial evaluation of HIV-1 subtype diversity at the largest HIV center in Rhode Island. Infect Genet Evol (2014) 0.83
Circulation of HIV-1 CRF02_AG among MSM population in central Italy: a molecular epidemiology-based study. Biomed Res Int (2013) 0.77
Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations. AIDS Res Hum Retroviruses (2016) 0.77
The Impact of Viral Suppression and Viral Breakthrough on Limited-Antigen Avidity Assay Results in Individuals with Clade B HIV Infection. AIDS Res Hum Retroviruses (2016) 0.75
Characterization of HIV diversity, phylodynamics and drug resistance in Washington, DC. PLoS One (2017) 0.75
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection. N Engl J Med (2015) 3.16
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med (2015) 3.13
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection. N Engl J Med (2015) 3.13
Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. J Clin Microbiol (2006) 2.45
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther (2013) 2.39
Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res (2007) 1.57
Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients. Hepatology (2015) 1.55
Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res (2007) 1.51
Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center. Clin Infect Dis (2013) 1.47
Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response. Hepatology (2012) 1.43
Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection. Lancet Infect Dis (2008) 1.42
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome. J Clin Invest (2014) 1.29
Persistently high prevalence and unrecognized HIV infection among men who have sex with men in Baltimore: the BESURE study. J Acquir Immune Defic Syndr (2011) 1.25
Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program. Am J Med Genet C Semin Med Genet (2014) 1.19
Factors associated with treatment failure in vertebral osteomyelitis requiring spinal instrumentation. Antimicrob Agents Chemother (2013) 1.13
Single-cell fluorescence imaging using metal plasmon-coupled probe 2: single-molecule counting on lifetime image. Nano Lett (2008) 1.07
Partner characteristics and undiagnosed HIV seropositivity among men who have sex with men only (MSMO) and men who have sex with men and women (MSMW) in Baltimore. AIDS Behav (2012) 1.02
High cancer-related mortality in an urban, predominantly African-American, HIV-infected population. AIDS (2013) 0.99
Phosphatase type 2A-dependent and -independent pathways for ATR phosphorylation of Chk1. J Biol Chem (2007) 0.99
Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R. Retrovirology (2010) 0.97
Fluorescent avidin-bound silver particle: a strategy for single target molecule detection on a cell membrane. Anal Chem (2009) 0.95
Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot study. Ann Intern Med (2014) 0.95
HIV risk among men who have sex with men only (MSMO) and men who have sex with men and women (MSMW) in Baltimore. J Homosex (2013) 0.95
Diagnosis and management of Lyme disease. Am Fam Physician (2012) 0.92
ATM-mediated transcriptional elevation of prion in response to copper-induced oxidative stress. J Biol Chem (2008) 0.91
Roles of HIV-1 auxiliary proteins in viral pathogenesis and host-pathogen interactions. Cell Res (2005) 0.91
Infectious diseases and the liver. Clin Liver Dis (2011) 0.89
Propionibacterium skull osteomyelitis treated with daptomycin. Clin Neurol Neurosurg (2009) 0.88
Anti-vpr activities of heat shock protein 27. Mol Med (2007) 0.87
Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells. J Virol (2005) 0.87
HIV-1 Vpr-induced cell death in Schizosaccharomyces pombe is reminiscent of apoptosis. Cell Res (2008) 0.87
Targeting γδ T cells for immunotherapy of HIV disease. Future Virol (2011) 0.86
Enhanced fluorescence images for labeled cells on silver island films. Langmuir (2008) 0.86
High interferon-stimulated gene ISG-15 expression affects HCV treatment outcome in patients co-infected with HIV and HCV. J Med Virol (2013) 0.86
Detection of CXCR4 receptors on cell surface using a fluorescent metal nanoshell. J Biomed Opt (2011) 0.85
Single center experience of a vancomycin resistant enterococcal endocarditis cohort. J Infect (2011) 0.85
Direct observation to chemokine receptor 5 on T-lymphocyte cell surface using fluorescent metal nanoprobes. Biochem Biophys Res Commun (2010) 0.84
Inteleukin-23 promotes interferon-α responsiveness in hepatitis C virus/HIV-coinfected patients. AIDS Res Hum Retroviruses (2014) 0.83
Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25. J Virol (2007) 0.83
Dividing roles of prion protein in staurosporine-mediated apoptosis. Biochem Biophys Res Commun (2006) 0.82
Antagonistic interaction of HIV-1 Vpr with Hsf-mediated cellular heat shock response and Hsp16 in fission yeast (Schizosaccharomyces pombe). Retrovirology (2007) 0.82
Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients. PLoS One (2013) 0.82
Influenza B-induced refractory cardiogenic shock: a case report. BMC Infect Dis (2013) 0.82
Gene expression profiles predict emergence of psychiatric adverse events in HIV/HCV-coinfected patients on interferon-based HCV therapy. J Acquir Immune Defic Syndr (2012) 0.82
Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy. Cell Biosci (2012) 0.81
HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome. PLoS One (2010) 0.81
HIV-1 viral protein R (Vpr) and its interactions with host cell. Curr HIV Res (2009) 0.81
From molecular diagnostics to personalized testing. Pharmacogenomics (2007) 0.80
Oxidative stress induced by HIV-1 F34IVpr in Schizosaccharomyces pombe is one of its multiple functions. Exp Mol Pathol (2009) 0.78
The use of preexposure treatments for HIV prophylaxis. HIV AIDS (Auckl) (2012) 0.78
APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication. Retrovirology (2008) 0.78
Update on the laboratory diagnosis and monitoring of HIV infection. Cell Res (2005) 0.78
Individual-Level and Partner-Level Predictors of Newly Diagnosed HIV Infection Among Black and White Men Who Have Sex with Men in Baltimore, MD. AIDS Behav (2015) 0.77
Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir. AIDS (2016) 0.77
The Impact of Preexposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model. J Acquir Immune Defic Syndr (2017) 0.76
Direct observation of chemokine receptors 5 on T-lymphocyte cell surfaces using fluorescent metal nanoprobes 2: Approximation of CCR5 populations. Biochem Biophys Res Commun (2011) 0.76
Zeocin for selection of bleMX6 resistance in fission yeast. Biotechniques (2011) 0.76
Regulation of unbalanced redox homeostasis induced by the expression of wild-type HIV-1 viral protein R (NL4-3Vpr) in fission yeast. Acta Biol Hung (2015) 0.75
Fluorescent metal nanoshell and CK19 detection on single cell image. Biochem Biophys Res Commun (2011) 0.75
Commentary on "Prevalence and evolution of drug resistance HIV-1 variants in Henan, China". Cell Res (2005) 0.75
Metal plasmon-coupled fluorescence imaging and label free coenzyme detection in cells. Biochem Biophys Res Commun (2012) 0.75
Differences and Similarities in HIV Testing Among Men Who have Sex with Men and Women (MSMW) and Men Who Have Sex with Men Only (MSMO). Open AIDS J (2012) 0.75
Syphilitic hepatitis treated with doxycycline in an HIV-infected patient and review of the literature. Sex Transm Dis (2014) 0.75
The Impact of Pre-Exposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model. J Acquir Immune Defic Syndr (2017) 0.75
Viral load decay in antiretroviral-naïve patients receiving once-daily tenofovir and emtricitabine plus twice-daily nevirapine. HIV Clin Trials (2009) 0.75
Double trouble. Am J Med (2008) 0.75
Lack of fluoroquinolone resistance in non-typhoidal salmonella bacteremia in HIV-infected patients in an urban US setting. J Int Assoc Physicians AIDS Care (Chic) (2009) 0.75
Cancer Knowledge and Opportunities for Education Among HIV-Infected Patients in an Urban Academic Medical Center. J Cancer Educ (2015) 0.75
A multiplex real-time PCR method for quantification of BK and JC polyomaviruses in renal transplant patients. Diagn Mol Pathol (2010) 0.75
Photo quiz. Diarrhea, anasarca, and severe hypoalbuminemia in an AIDS patient. Diagnosis: AIDS-related visceral Kaposi sarcoma (KS) with protein-losing enteropathy (PLE). Clin Infect Dis (2015) 0.75
Pannus attack: septic thrombophlebitis. Am J Med (2012) 0.75
Upper gastrointestinal bleeding in a patient with HIV infection. Clin Infect Dis (2009) 0.75
An editorial overview: HIV/AIDS in China. Cell Res (2005) 0.75